Packer M - Search Results

1

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.

Massie BM, Packer M, Hanlon JT, Combs DT. Massie BM, et al. Among authors: packer m. J Am Coll Cardiol. 1983 Aug;2(2):338-44. doi: 10.1016/s0735-1097(83)80172-7. J Am Coll Cardiol. 1983. PMID: 6345633 Free article.

2

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.

Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Gradman A, et al. Among authors: packer m. J Am Coll Cardiol. 1989 Sep;14(3):564-70; discussion 571-2. doi: 10.1016/0735-1097(89)90093-4. J Am Coll Cardiol. 1989. PMID: 2768707 Free article.

3

Deleterious effects of hydralazine in patients with pulmonary hypertension.

Packer M, Greenberg B, Massie B, Dash H. Packer M, et al. N Engl J Med. 1982 Jun 3;306(22):1326-31. doi: 10.1056/NEJM198206033062203. N Engl J Med. 1982. PMID: 7070457

4

Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study.

Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager MA. Packer M, et al. J Am Coll Cardiol. 1993 Jul;22(1):65-72. doi: 10.1016/0735-1097(93)90816-j. J Am Coll Cardiol. 1993. PMID: 8509565 Free article. Clinical Trial.

5

Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan.

Massie BM, Shah NB, Pitt B, Packer M. Massie BM, et al. Among authors: packer m. Am Heart J. 1996 Jul;132(1 Pt 1):130-6. doi: 10.1016/s0002-8703(96)90401-9. Am Heart J. 1996. PMID: 8701855 Clinical Trial.

6

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA, Rydén L. Massie BM, et al. Among authors: packer m. Arch Intern Med. 2001 Jan 22;161(2):165-71. doi: 10.1001/archinte.161.2.165. Arch Intern Med. 2001. PMID: 11176729 Clinical Trial.

7

Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.

Packer M, Medina N, Yushak M. Packer M, et al. J Am Coll Cardiol. 1984 Apr;3(4):1035-43. doi: 10.1016/s0735-1097(84)80364-2. J Am Coll Cardiol. 1984. PMID: 6323565 Free article.

8

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.

Packer M, McMurray J, Massie BM, Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets DL. Packer M, et al. J Card Fail. 2005 Feb;11(1):12-20. doi: 10.1016/j.cardfail.2004.05.006. J Card Fail. 2005. PMID: 15704058 Clinical Trial.

9

Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.

Packer M, Lee WH, Medina N, Yushak M. Packer M, et al. J Am Coll Cardiol. 1985 Sep;6(3):635-45. doi: 10.1016/s0735-1097(85)80125-x. J Am Coll Cardiol. 1985. PMID: 2993397 Free article.

10

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.

Massie B, Bourassa M, DiBianco R, Hess M, Konstam M, Likoff M, Packer M. Massie B, et al. Among authors: packer m. Circulation. 1985 May;71(5):963-71. doi: 10.1161/01.cir.71.5.963. Circulation. 1985. PMID: 3886191 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,042 results

Search Page